Overview

MK0431 Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-040)

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
This is a clinical study to determine the safety and efficacy of an investigational drug in patients with type 2 diabetes mellitus.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Sitagliptin Phosphate